Literature DB >> 16785998

Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.

Y Midorikawa1, S Yamamoto, S Ishikawa, N Kamimura, H Igarashi, H Sugimura, M Makuuchi, H Aburatani.   

Abstract

Genomic amplification of oncogenes and inactivation of suppressor genes are critical in the pathogenesis of human cancer. To identify chromosomal alterations associated with hepatocarcinogenesis, we performed allelic gene dosage analysis on 36 hepatocellular carcinomas (HCCs). Data from high-density single-nucleotide polymorphism arrays were analysed using the Genome Imbalance Map (GIM) algorithm, which simultaneously detects DNA copy number alterations and loss of heterozygosity (LOH) events. Genome Imbalance Map analysis identified allelic imbalance regions, including uniparental disomy, and predicted the coexistence of a heterozygous population of cancer cells. We observed that gains of 1q, 5p, 5q, 6p, 7q, 8q, 17q and 20q, and LOH of 1p, 4q, 6q, 8p, 10q, 13q, 16p, 16q and 17p were significantly associated with HCC. On 6q24-25, which contains imprinting gene clusters, we observed reduced levels of PLAGL1 expression owing to loss of the unmethylated allele. Finally, we integrated the copy number data with gene expression intensity, and found that genome dosage is correlated with alteration in gene expression. These observations indicated that high-resolution GIM analysis can accurately determine the localizations of genomic regions with allelic imbalance, and when integrated with epigenetic information, a mechanistic basis for inactivation of a tumor suppressor gene in HCC was elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785998     DOI: 10.1038/sj.onc.1209537

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.

Authors:  Xiaoying Zhang; Hiu Ming Li; Zhiyan Liu; Gengyin Zhou; Qinghui Zhang; Tingguo Zhang; Jianping Zhang; Cuijuan Zhang
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

2.  Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.

Authors:  Akira Watanabe; Hideki Ogiwara; Shogo Ehata; Akitake Mukasa; Shumpei Ishikawa; Daichi Maeda; Keisuke Ueki; Yasushi Ino; Tomoki Todo; Yasuhiro Yamada; Masashi Fukayama; Nobuhito Saito; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-12       Impact factor: 11.205

3.  Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.

Authors:  T Harada; C Chelala; V Bhakta; T Chaplin; K Caulee; P Baril; B D Young; N R Lemoine
Journal:  Oncogene       Date:  2007-10-22       Impact factor: 9.867

4.  Uniparentalism in sporadic colorectal cancer is independent of imprint status, and coordinate for chromosomes 14 and 18.

Authors:  Huferesh K Darbary; Smitha S Dutt; Sheila J Sait; Norma J Nowak; Roy E Heinaman; Daniel L Stoler; Garth R Anderson
Journal:  Cancer Genet Cytogenet       Date:  2009-03

5.  Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

Authors:  Derek Y Chiang; Augusto Villanueva; Yujin Hoshida; Judit Peix; Philippa Newell; Beatriz Minguez; Amanda C LeBlanc; Diana J Donovan; Swan N Thung; Manel Solé; Victoria Tovar; Clara Alsinet; Alex H Ramos; Jordi Barretina; Sasan Roayaie; Myron Schwartz; Samuel Waxman; Jordi Bruix; Vincenzo Mazzaferro; Azra H Ligon; Vesna Najfeld; Scott L Friedman; William R Sellers; Matthew Meyerson; Josep M Llovet
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 6.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

7.  Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.

Authors:  Dong Wang; Zhong-Zheng Zhu; Hongmei Jiang; Jiayi Zhu; Wen-Ming Cong; Bing-Ji Wen; Song-Qin He; Shu-Fang Liu
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

8.  Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.

Authors:  Subramaniam Mohana Devi; Vellingiri Balachandar; Meyyazhagan Arun; Shanmugam Suresh Kumar; Balasubramanian Balamurali Krishnan; Keshavarao Sasikala
Journal:  Dig Dis Sci       Date:  2012-10-02       Impact factor: 3.199

Review 9.  Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.

Authors:  Paola Rebuzzini; Maurizio Zuccotti; Carlo Alberto Redi; Silvia Garagna
Journal:  Cell Mol Life Sci       Date:  2016-03-09       Impact factor: 9.261

10.  Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.

Authors:  Tsuyoshi Yoshida; Takumi Kobayashi; Masaya Itoda; Taika Muto; Ken Miyaguchi; Kaoru Mogushi; Satoshi Shoji; Kazuro Shimokawa; Satoru Iida; Hiroyuki Uetake; Toshiaki Ishikawa; Kenichi Sugihara; Hiroshi Mizushima; Hiroshi Tanaka
Journal:  Cancer Inform       Date:  2010-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.